Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
- 1 August 2002
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 2 (8), 487-493
- https://doi.org/10.1016/s1473-3099(02)00346-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Live attenuated HIV vaccines: Predicting the tradeoff between efficacy and safetyProceedings of the National Academy of Sciences of the United States of America, 2001
- A Tale of Two Futures: HIV and Antiretroviral Therapy in San FranciscoScience, 2000
- Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug useAIDS, 2000
- HIV-1 Drug Resistance in Newly Infected IndividualsJama-Journal Of The American Medical Association, 1999
- Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV InfectionJama-Journal Of The American Medical Association, 1999
- Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 1999
- Global elimination of trachoma: How frequently should we administer mass chemotherapy?Nature Medicine, 1999
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsThe New England Journal of Medicine, 1998
- Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework.Journal of Molecular Medicine, 1998
- Control Strategies for Tuberculosis Epidemics: New Models for Old ProblemsScience, 1996